SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening. Vanhulle E, Stroobants J, Provinciael B, Camps A, et al. Antiviral Res 2022 May 17:105342. doi: 10.1016/j.antiviral.2022.105342.

Read + Share

Amedeo Smart

Independent Medical Education

Vanhulle E, Stroobants J, Provinciael B, Camps A, et al. SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening. Antiviral Res 2022 May 17:105342. doi: 10.1016/j.antiviral.2022.105342.
PMID: 35595082